Picture of Novakand Pharma AB logo

NOVKAN — Novakand Pharma AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Kancera AB Q2 Operating Loss Narrows To SEK 10.2 Million

Aug 24 (Reuters) - Kancera AB  KANC.ST :
    * Q2  OPERATING  LOSS SEK 10.2 MILLION VERSUS LOSS SEK 18.0 MILLION YEAR AGO

Source text for Eikon:  ID:nWkrbJSTb3 
Further company coverage:  KANC.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Novakand Pharma AB

See all news